Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy: A cytokine profiling study of two cases

H. Umemura; O. Yamasaki; S. Morizane; K. Iwatsuki

doi:10.1093/annonc/mdx325

Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy: A cytokine profiling study of two cases

H. Umemura, O. Yamasaki, S. Morizane, K. Iwatsuki

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2624-2625
Number of pages	2
Journal	Annals of Oncology
Volume	28
Issue number	10
DOIs	https://doi.org/10.1093/annonc/mdx325
Publication status	Published - Oct 2017

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdx325

Cite this

@article{a8a742d5eb934df7afbe8c37f96cfe17,

title = "Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy: A cytokine profiling study of two cases",

author = "H. Umemura and O. Yamasaki and S. Morizane and K. Iwatsuki",

note = "Funding Information: This work was supported by Okayama University Hospital Biobank (Okadai Biobank), Japan. Funding Information: This work was partially supported by a grant-in-aid (No. AC-1-20160625121842-396402) from Chugai Pharmaceutical Co. Ltd., Tokyo, Japan. ",

year = "2017",

month = oct,

doi = "10.1093/annonc/mdx325",

language = "English",

volume = "28",

pages = "2624--2625",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy

T2 - A cytokine profiling study of two cases

AU - Umemura, H.

AU - Yamasaki, O.

AU - Morizane, S.

AU - Iwatsuki, K.

N1 - Funding Information: This work was supported by Okayama University Hospital Biobank (Okadai Biobank), Japan. Funding Information: This work was partially supported by a grant-in-aid (No. AC-1-20160625121842-396402) from Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.

PY - 2017/10

Y1 - 2017/10

UR - http://www.scopus.com/inward/record.url?scp=85030569407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030569407&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx325

DO - 10.1093/annonc/mdx325

M3 - Letter

C2 - 28651362

AN - SCOPUS:85030569407

VL - 28

SP - 2624

EP - 2625

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -

Possible macrophage activation in melanoma patients receiving combined kinase inhibitor therapy following anti-PD-1 therapy: A cytokine profiling study of two cases

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this